Drug Trial Radar · NCT07663903
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment
Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Apr 14, 2026
Primary completion
Feb 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Hangzhou Gensciences Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 12 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The indication for this product is to control bleeding in patients with hemophilia A (congenital deficiency of factor VIII). The primary objective: Evaluation of the efficacy of recombinant human coagulation factor VIII-Fc fusion protein for injection (FRSW107) as an on-demand treatment in previously treated patients with severe hemophilia A. Secondary objectives: Evaluation of the safety and immunogenicity of FRSW107 as an on-demand therapy in previously treated patients with severe hemophilia A. Evaluate the on-demand treatment's PK profile of FRSW107 in previously treated patients with severe hemophilia A based on population pharmacokinetic (PopPK) methods ; preliminarily investigate the exposure-response (E-R) relationship of FRSW107 on-demand treatment in these patients if data permit.
Conditions
- Severe Hemophilia A
Interventions
FRSW107Drug
Treatment for 6 months as needed.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The haemostatic effective rateTime frame: 6 months
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Fuyang Hospital, Affiliated to Anhui Medical University
Fuyang, China
Fujian Medical University Union Hospital
Fuzhou, China
Ganzhou People's Hospital
Ganzhou, China
Nanfang Hospital of Southern Medical University
Guangzhou, China
Anhui Provincial Hospital
Hefei, China
Huai'an Second People's Hospital
Huai'an, China
Jinan central hospital
Jinan, China
The Second Affiliated Hospital of Kunming Medical University
Kunming, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, China
Affiliated Hospital of Nantong University
Nantong, China
The First Affiliated Hospital of Nanyang Medical College
Nanyang, China
Qinghai Provincial People's Hospital
Qinghai, China
Rizhao People's Hospital
Rizhao, China
The Second Hospital of Hebei Medical University
Shijiazhuang, China
The Second Hospital of Shanxi Medical University
Taiyuan, China
North China University of Science and Technology Affiliated Hospital
Tangshan, China
Wenzhou People's Hospital
Wenzhou, China
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology.
Wuhan, China
Affiliated Hospital of Jiangnan University
Wuxi, China
Xi'an Central Hospital
Xi'an, China
Subei People's Hospital of Jiangsu province
Yangzhou, China
Henan Cancer Hospital
Zhengzhou, China
Zhengzhou People's Hospital
Zhengzhou, China
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Tianjin, Tianjin Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.